Conference Dates: Jun 07-11, 2010
Philadelphia, PA[edit Location]
The biotechnology and pharmaceuticals industries have experienced rapid advances in science, increasingly complex alliances between research and development, intense global competition, mega-mergers, and new regulations and shifts in policies. To successfully lead your company through this complex environment, you need to Understand the profound strategic implications of these changes — and Understand them across the key functions of the business: discovery, marketing, finance, and business development.
The Wharton/Windhover Program gives current and future industry leaders insight into the changes and challenges of each key area of the business. Taught by CEOs, top researchers and drug developers, senior marketing executives, policy and pricing experts, industry deal-makers, and Wharton faculty, the course will give you broad perspectives and practical tools. Faculty discuss the management implications of the new techniques of drug discovery, marketing and pricing in the current environment, financial evaluation and deals, and mergers and alliances.
The Wharton/Windhover Program combines the academic insights of health care management faculty and industry analysts with the best practical experience of senior drug company executives. This academia-industry collaboration distills the best of academic research and practical experience into a powerful and focused one-week session.
[edit description]Click here to register.[edit ]
Industries[edit]
Fee: $8450[edit ]